Each one in plain English, with the numbers worked through for a shareholder.
10 Sept 2021regulatory community update▼ BadMajor
The Hong Kong court granted the interim injunction stopping Astron from implementing the demerger approved on 19 July. The in-specie distribution, due by 13 September, is on hold. Astron says the injunction is the last obstacle to the demerger, and will oppose a permanent order.
A holder of about 15,000 CDIs (about A$6,000) has applied in Hong Kong for an interim injunction to stop the shareholder-approved demerger. Astron calls it vexatious and frivolous and will oppose it. The demerger is due by 13 September 2021.
Re-release of the 30 July quarterly report after the company was advised that required disclosures, including JORC Code items, were missing. The earlier version is to be disregarded. The visible content repeats the earlier Donald figures.
Second supplementary prospectus: the Chinese regulatory approvals are still outstanding, so the demerger distribution is pushed back again, to no later than 6 September (later table shows 13 September 2021), with record date 3 September.
June 2021 quarter report restates Donald plans: 602Mt reserve, Stage 1 of 194Mt at 5.3% HM, and a switch to doing all processing in Australia. Work Plan still to be submitted and granted; the company is moving toward the feasibility study. Funding is not resolved in the visible text.
July 2021 investor presentation promoting Donald as a tier 1 resource and a globally significant new source of mineral sands supply. Visible text is disclaimers only; no new figures are shown, so it appears to repeat known Donald facts.
June 2021 quarter cash flow: cash $2.16m, down from $3.80m. Operating cash outflow was $1.08m. Facilities of $13.6m are fully drawn, mostly related-party loans. The report estimates 1.72 quarters of funding available.
Shareholders approved the demerger and the sale of the processing and sales business at the 19 July EGM, but some PRC regulatory approvals are still pending. Distribution completion is pushed to no later than 30 August 2021, record date 20 August.
George Lloyd joins as non-executive director, with experience including RGC Limited and its 1998 merger that formed Iluka. Astron says shareholders approved the China demerger, so it can focus on Donald. He follows Dr Mark Elliott's January 2021 appointment.
Managing Director's address at the 19 July 2021 EGM, themed on commercialising Donald. The visible text is disclaimers and competent person statements, with no new figures shown. Repeats known Donald facts; the demerger vote outcome is covered in later announcements.
Astron proposes demerging its China downstream processing and sales business into unlisted Titanium Hong Kong, distributed one share per Astron security. Astron would keep Donald and Niafarang. Shareholders vote at an EGM on 19 July 2021, which also covers option plans.
Short-form prospectus for the proposed in-specie distribution of 122,479,784 Titanium Hong Kong shares to Astron securityholders, one per security, for the China business demerger. Directors call the shares speculative. Depends on the 19 July 2021 EGM vote; the detail sits in the Notice of Meeting.
Further revised metallurgical testwork announcement after the company was advised Section 3 of the 12 May version should not be included. Earlier versions are to be disregarded. Results are unchanged.
Re-release of the 8 April zircon whiteness announcement, adding information the company was told was required, including the proved (310Mt) and probable (292Mt) reserve split. Test results are unchanged.
Re-release of the 30 March metallurgical testwork announcement, adding JORC Code tables and information the company was told was required. Headline results are unchanged.
March 2021 quarter: no commercial production. Donald Stage 1 targets about 120ktpa zircon, 200ktpa titania and 16ktpa rare earths; 2021 is to deliver a feasibility study. Stage 2 reserves are 408Mt. Funding is still to be determined.
Reviewed half-year report released. A non-cash write-back of a related-party payable was moved from other income to a capital reserve, cutting half-year profit from $3.31m to $1.86m. Still $4.30m better than the prior-year loss.
Reviewed half-year report: profit $1.86m, sales up 82.4% to $9.30m, cash $1.40m. The auditor included a going-concern emphasis of matter. Replaces the unreviewed version and confirms the lower profit.
Donald zircon tested whiter than three competitor premium zircons (brightness 94.84 vs 93.57-94.39). Premium zircon is about 95,000tpa of Stage 1 output and needs no acid leaching. Astron says this lets it advance offtake talks with customers.
Pilot tests on Donald's 24t concentrate gave rare earth concentrate (51.2% REE) at up to 94.6% recovery, zircon recovery up to 90.8% and titania recovery up to 94.4%. Builds on the earlier recoveries and supports the move to a feasibility study in 2021.
Half-year to 31 December 2020 lodged unreviewed under ASIC/ASX COVID relief. Reports revenue up 109.3% to $11.06m and a $3.31m profit, against a prior loss. Figures may change once the auditor's review is finished.
Donald Ore Reserve rises 141Mt (31%) to 602Mt at 4.8% heavy minerals, about 5.4Mt of contained zircon. This replaces the 2012/2013 reserve of 461Mt that Astron had said was unchanged, and is a key step toward the feasibility study.
17 Feb 2021director officer appointment● NeutralMajor
Tiger Brown, son of late founder Alex Brown, becomes Managing Director at $100,000 a year, replacing Kang Rong, who stays as executive director and Chief Marketing Officer. His stated focus is a Definitive Feasibility Study for Donald. This resolves the board structure review.
December 2020 quarter: no production. Donald pilot produced 24t of concentrate; revised recoveries 88.5% TiO2, 94.3% ZrO2, 93.8% CeO2 (earlier 85.2/94.6/95.9%). Rare-earth flotation tests give confidence in over 90% recovery. Ore Reserve update planned for early 2021; feasibility targeted in 2021.
Dr Mark Elliott joins as non-executive director. He was Managing Director of Zirtanium when it acquired the Donald deposit in 2000, so brings deep knowledge of it. Astron says the appointment strengthens the board as Donald scoping and evaluation is finalised.
AGM address in Sydney positions Donald as a major mineral sands production source. The excerpt shows general company background, and no new figures or decisions are visible in the text provided.
Astron admits it accidentally left the name of its independent director out of the governance statement. The independent director is Chairman Gerard King. Administrative correction only.
Re-lodged Appendix 4G, dated 29 October 2020, to fix the omission of the independent director's name. Administrative re-filing with no new business information.
Annual report for FY20 repeats the audited results. Chairman pays tribute to founder Alex Brown, who died 30 November 2019, and says Donald stage 1 would produce up to 615,000t of concentrate a year, with construction expected to start in 2021.